• Lung Cancer Group Cologne
  • Contact
  • Privacy Policy
  • English
    • Deutsch (German)
Netzwerk Genomische Medizin Lungenkrebs
  • Doctors
    • Information
      • Service invoicing
      • Service invoicing for pathologists
    • Clinical trials
      • Lung Cancer Study Group
      • General information
  • Patients
    • General information
      • Driver mutations in lung cancer
      • New immunotherapeutic therapeutic approaches
      • Second Opinion service
      • Molecular Diagnostics
      • New therapeutic approaches from genomic research
    • Clinical trials
      • Lung Cancer Study Group
      • General information
      • What is a clinical trial?
      • Participation in a trial
    • Find doctors nearby
  • The Network
    • Aims
    • Funding
    • Our team
    • Related links
  • Driver mutations
  • Diagnostics
  • Hybrid-capture
  • Fast-track analysis for first-line treatment
Select Page

 

PD-L1 expression in non-smell cell lung cancer: Coorelations with genetic alterations.

 

Scheel AH1, Ansén S2, Schultheis AM1, Scheffler M2, Fischer RN2, Michels S2, Hellmich M3, George J4, Zander T2, Brockmann M5, Stoelben E6, Groen H7, Timens W8, Perner S9, von Bergwelt-Baildon M2, Büttner R1, Wolf J2.

 

 

Journal: Oncoimmunology
published: 2016 March 16

 

 

  • © 2016-2018 Network Genomic Medicine (NGM)
  • Contact
  • Imprint
  • Privacy Policy

Designed by Elegant Themes | Powered by WordPress